European Plant Protein Business and Investment Opportunities to 2027: Market Size and Forecast Across 50+ Segments


These 3 Cathie Wood Stocks Are Set to Rip Higher By 40% (Or More)

The markets lately are a mix of gains and volatility, and it’s tough, sometimes, for investors to make sense of it. In times like these, it makes sense to turn to the experts. Cathie Wood is one such expert, an investor whose stock choices have consistently outperformed the overall markets. A protégé of famed economist Arthur Laffer, market guru Wood has built her reputation on her clear view of the markets. Her firm is Ark Invest, whose Innovation ETF has over $52 billion in assets under management, making it one of the largest institutional investors on the scene. And better yet, Wood’s stock choices paid back during the ‘corona year;’ the ETF’s overall return in 2020 was an astounding 170%. With returns like that, it’s clear Cathie Wood knows what she’s talking about when she

Read More

Small business center offers farmers market webinar | Business

The University of Scranton Small Business Development Center will offer a two-part webinar series to help local farmers and individuals planning to sell food and other products at farmers markets across the region this season.

Building a Great Farmers’ Market Booth, Part One will take place at 6 p.m. on Tuesday, April 20 and Part Two: Building Displays at 6 p.m. on Tuesday, May 18. Both webinars will be held on Zoom and are free.

This two-part series, presented by boutique consulting firm Small Potatoes, will give practical tips on selling at a farmers market while maximizing the return on the time invested. Part one will cover choosing the right market, taking pre-orders, customer service, capturing wholesale accounts at the market, and how the pandemic has changed market operations.

Part two will dive into how building strong displays can draw customers to your booth and how the public’s changing

Read More

Sun Pharma Alembic Recall Products In The US Market

Leading drug makers Sun Pharma and Alembic Pharmaceuticals are recalling different products in the US, the world’s largest market for medicines.

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), US-based unit of Sun Pharma is recalling 91,211 pre-filled syringes of Ganirelix Acetate injection due to ‘failed impurities/degradation specifications’.

The affected lot has been manufactured at Sun Pharma’s Halol plant in Gujarat and distributed in the US by Ferring Pharmaceuticals Inc, the report stated.

The drug major initiated the recall on March 15 this year and the USFDA has classified it as Class II action, which is undertaken in a situation ‘in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote’.

Ganirelix Acetate Injection is used in assisted reproduction to control ovulation.

Princeton (New Jersey)

Read More

Samsung Aims To Grow Over Twofold In Monitor Market

South Korean consumer electronics major Samsung aims to grow over twofold in the computer monitor market, and expects to become the leading player in its premium segment (27 inches and above), said a senior company official.

The company is focusing towards the premium-end of the segment and strengthening its product portfolio, where it expects the contribution to be double to 40 per cent this year from 20 per cent of the last year, said Samsung India Vice-President (Consumer Electronics Enterprise Business) Puneet Sethi.

Samsung, which last week introduced a new range of ‘Do-It-All’ smart monitors with inbuilt apps allowing users to multitask, expects it to be an ideal product for the people working remotely under the work-from-home culture.

‘In 2021, we expect to grow 140 per cent in overall monitors and 150 per cent in the premium segment,’ Sethi told PTI.

Last year, Samsung had 60 per cent overall growth

Read More